DalsnaFinance Account

Altria $MO

Consumer Staples · Tobacco · NYSE/NASDAQ

S&P 500 Russell 1000 Virginia

Create a scorecard

$73.84

+0.71 (+0.97%)

As of Oct 15, 2026, 9:55 PM EDT

Price history

Loading chart…

Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 2, 2026, the first target we tracked for MO.

Altria (MO) is trading up at $73.84 (+0.97%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Consumer Staples sector.

Analyst price targets on MO

One firm's current price target on Altria: $60 — 19% below the current $73.8. Each is tracked to its date and scored the same way a member's call is.

Jefferies $67 → $60 by Oct 2027 Underperform Oct 2, 2026 via Investing.com · Jefferies's track record

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Altria revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)

Altria annual financial statements
	FY2016Dec 2016	FY2017Dec 2017	FY2018Dec 2018	FY2019Dec 2019	FY2020Dec 2020	FY2021Dec 2021	FY2022Dec 2022	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$25.7B	$25.6B	$25.4B	$25.1B	$26.2B	$26.0B	$25.1B	$24.5B	$24.0B	$23.3B
Growth (year over year)	+1.2%	−0.7%	−0.8%	−1.0%	+4.2%	−0.5%	−3.5%	−2.4%	−1.9%	−3.1%
Gross profit	$11.6B	$12.0B	$12.3B	$12.7B	$13.0B	$14.0B	$14.2B	$14.3B	$14.4B	$14.5B
Gross margin	45.0%	46.8%	48.3%	50.6%	49.8%	53.8%	56.8%	58.3%	59.8%	62.5%
Operating income	$8.76B	$9.59B	$9.12B	$10.3B	$10.9B	$11.6B	$11.9B	$11.5B	$11.2B	$9.90B
Operating margin	34.0%	37.5%	35.9%	41.1%	41.6%	44.4%	47.5%	47.2%	46.8%	42.5%
Net income	$14.2B	$10.2B	$6.96B	−$1.29B	$4.47B	$2.48B	$5.76B	$8.13B	$11.3B	$6.95B
Net margin	55.3%	40.0%	27.5%	−5.1%	17.1%	9.5%	23.0%	33.2%	46.9%	29.8%
EPS (diluted)	$7.28	$5.31	$3.68	−$0.70	$2.40	$1.34	$3.19	$4.57	$6.54	$4.12
Balance sheet
Cash and equivalents	$4.57B	$1.25B	$1.33B	$2.12B	$4.95B	$4.54B	$4.03B	$3.69B	$3.13B	$4.47B
Total assets	$45.9B	$43.2B	$55.5B	$49.3B	$47.4B	$39.5B	$37.0B	$38.6B	$35.2B	$35.0B
Total liabilities	$33.1B	$27.8B	$40.6B	$42.9B	$44.4B	$41.1B	$40.9B	$42.1B	$37.4B	$38.5B
Long-term debt	$13.9B	$13.0B	$11.9B	$27.0B	$28.0B	$26.9B	$25.1B	$25.1B	$23.4B	$24.1B
Shareholders' equity	$12.8B	$15.4B	$14.8B	$6.22B	$2.84B	−$1.61B	−$3.97B	−$3.54B	−$2.24B	−$3.50B
Cash flow
Operating cash flow	$3.83B	$4.90B	$8.39B	$7.84B	$8.38B	$8.40B	$8.26B	$9.29B	$8.75B	$9.29B
Capital expenditure	$189.0M	$199.0M	$238.0M	$246.0M	$231.0M	$169.0M	$205.0M	$196.0M	$142.0M	$216.0M
Free cash flow	$3.64B	$4.70B	$8.15B	$7.59B	$8.15B	$8.24B	$8.05B	$9.09B	$8.61B	$9.07B
Dividends paid	$4.51B	$4.81B	$5.42B	$6.07B	$6.29B	$6.45B	$6.60B	$6.78B	$6.84B	$6.96B
Share buybacks	$1.03B	$2.92B	$1.67B	$845.0M	$0	$1.68B	$1.82B	$1.00B	$3.40B	$1.00B

RevenueNet incomeNet margin (right axis, %)

Altria quarterly financial statements
	Q3 FY24Sep 2024	Q4 FY24^†Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Income statement
Revenue	$6.26B	$5.97B	$5.26B	$6.10B	$6.07B	$5.85B	$5.43B	$6.11B
Growth (year over year)	−0.4%	−0.0%	−5.7%	−1.7%	−3.0%	−2.1%	+3.2%	+0.1%
Gross profit	$3.81B	$3.60B	$3.25B	$3.85B	$3.81B	$3.63B	$3.51B	$3.82B
Gross margin	60.8%	60.3%	61.8%	63.1%	62.8%	62.1%	64.6%	62.5%
Operating income	$3.15B	$2.88B	$1.79B	$3.23B	$3.23B	$1.65B	$2.96B	$3.14B
Operating margin	50.4%	48.2%	34.0%	52.9%	53.2%	28.2%	54.5%	51.3%
Net income	$2.29B	$3.04B	$1.08B	$2.38B	$2.38B	$1.12B	$2.18B	$2.30B
Net margin	36.6%	50.9%	20.5%	39.0%	39.1%	19.1%	40.2%	37.6%
EPS (diluted)	$1.34	$1.78	$0.63	$1.41	$1.41	$0.67	$1.30	$1.37
Balance sheet
Cash and equivalents	$1.90B	$3.13B	$4.73B	$1.29B	$3.47B	$4.47B	$3.53B	$2.37B
Total assets	$34.2B	$35.2B	$35.8B	$32.3B	$35.0B	$35.0B	$34.6B	$33.4B
Total liabilities	$37.6B	$37.4B	$39.2B	$35.5B	$37.6B	$38.5B	$37.7B	$36.0B
Long-term debt	$23.6B	$23.4B	$23.4B	$23.7B	$24.1B	$24.1B	$24.1B	$22.9B
Shareholders' equity	−$3.47B	−$2.24B	−$3.51B	−$3.26B	−$2.65B	−$3.50B	−$3.21B	−$2.67B
Cash flow
Operating cash flow	$2.61B	$3.34B	$2.72B	$205.0M	$3.09B	$3.27B	$2.32B	$719.0M
Capital expenditure	$31.0M	$47.0M	$38.0M	$32.0M	$54.0M	$92.0M	$93.0M	$57.0M
Free cash flow	$2.58B	$3.29B	$2.68B	$173.0M	$3.04B	$3.18B	$2.23B	$662.0M
Dividends paid	$1.69B	$1.74B	$1.73B	$1.72B	$1.72B	$1.78B	$1.78B	$1.78B
Share buybacks	$680.0M	$310.0M	$326.0M	$274.0M	$112.0M	$288.0M	$280.0M	$55.0M

From Altria's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Altria

Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco. It operates worldwide and is headquartered in the city of Richmond, Virginia.

Source: Wikipedia — Altria